Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical finasteride plus minoxidil versus minoxidil alone in male androgenetic alopecia
IRCT20120215009014N605Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in androgenetic alopecia (AGA) comparing Topical minoxidil + topical finasteride with Topical minoxidil monotherapy (2 arms). Primary endpoints: Average hair concentration, Average hair diameter and 2 more. Started May 2026; status: completed.
02
Drugs
minoxidilfinasteride
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on IRCT20120215009014N605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N605.